Insights & Perspectives

Filter by














Therapeutic Area / Research

Search Insights:
Showing 1 to 10 of 430
Filter by: Unfiltered

Blog Post | Dec 7, 2018

Profiling South Korean Statin Users Leads to Better Outcomes

To better understand the characteristics of statin users in South Korea, we investigated the prevalence of comorbidities and the burden of healthcare resource utilization using 5 years of Health Insurance Review and Assessment-National Patients Sample (HIRA-NPS) data.

Read more | | Share

Blog Post | Dec 6, 2018

KATHERINE extends Roche / Genentech’s reign in HER2+ breast cancer

Co-authored by Stephanie Hawthorne

Read more | | Share

Blog Post | Dec 4, 2018

MAIA: Another bright star for Darzalex in multiple myeloma

Co-authored by Stephanie Hawthorne

Read more | | Share

Blog Post | Dec 4, 2018

Imbruvica combined with Rituxan Outshines FCR Chemoimmunotherapy in Young, Fit Patients in Front-line CLL

Treatment of CLL just became even more chemo free as Imbruvica in combination with Rituxan was shown to be more effective than FCR, the standard chemoimmunotherapy for young, fit patients without TP53 mutated / del17p high-risk disease.

Read more | | Share

Blog Post | Dec 4, 2018

The Golden Years of AML Therapy: New options for unfit/elderly patients

Monumental advances continue in AML with the latest data from ASH 2018 for the newest approvals in unfit AML.

Read more | | Share

Blog Post | Dec 3, 2018

Dislodging the incumbent: Ninlaro poised for an upset win as post-transplant maintenance in multiple myeloma

Co-authored by Stephanie Amato

Read more | | Share

Article | Nov 19, 2018

Four Key Questions About Data Analytics

Read more | | Share

Article | Nov 12, 2018

Pharm Exec's 2019 Pipeline Report

Read more | | Share

Case Study | Nov 11, 2018

Classic Market Research Coupled with Unique Framework Yields Valuable Patient Insights for New Oncology Therapies

Kantar Health recently conducted a breakthrough study about the nutritional journeys of Chinese oncology patients that offers valuable information for the development of advanced therapies.

Read more | | Share

Blog Post | Nov 8, 2018

Think You Know Korea?

Pharma executives aiming to do business in Korea must take several key steps to ensure success in this prime growth market.

Read more | | Share
Page  < 12345678910 >